Definitive Healthcare (NASDAQ:DH) Stock Price Up 6.8% – What’s Next?

Definitive Healthcare Corp. (NASDAQ:DH) traded up 6.8% during mid-day trading on Tuesday . The stock traded as high as $4.91 and last traded at $4.94. 899,586 shares traded hands during mid-day trading, an increase of 15% from the average session volume of 781,061 shares. The stock had previously closed at $4.62.

Analyst Ratings Changes

Several analysts have issued reports on the company. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Barclays reaffirmed an “underweight” rating and set a $4.00 price objective on shares of Definitive Healthcare in a report on Monday, January 13th. Finally, Stephens initiated coverage on shares of Definitive Healthcare in a research note on Friday, December 20th. They issued an “equal weight” rating and a $5.00 target price for the company. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $5.72.

Definitive Healthcare Stock Up 8.4 %

The company’s 50-day moving average price is $4.38 and its 200 day moving average price is $4.45. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The stock has a market cap of $578.76 million, a PE ratio of -1.62, a price-to-earnings-growth ratio of 3.54 and a beta of 1.41.

Definitive Healthcare (NASDAQ:DH) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.08 by ($0.03). The company had revenue of $62.70 million during the quarter, compared to the consensus estimate of $61.66 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. During the same period last year, the business earned $0.01 EPS. As a group, analysts forecast that Definitive Healthcare Corp. will post 0.15 EPS for the current fiscal year.

Insider Buying and Selling at Definitive Healthcare

In other news, insider William Moschella sold 45,000 shares of Definitive Healthcare stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total transaction of $211,500.00. Following the completion of the sale, the insider now directly owns 433,830 shares in the company, valued at approximately $2,039,001. This trade represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 14.84% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Millennium Management LLC purchased a new position in shares of Definitive Healthcare during the 2nd quarter valued at about $9,283,000. Massachusetts Financial Services Co. MA lifted its holdings in Definitive Healthcare by 36.8% in the third quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock valued at $27,058,000 after acquiring an additional 1,626,813 shares during the period. 272 Capital LP boosted its holdings in Definitive Healthcare by 74.8% during the third quarter. 272 Capital LP now owns 1,114,080 shares of the company’s stock worth $4,980,000 after buying an additional 476,766 shares in the last quarter. State Street Corp grew its position in shares of Definitive Healthcare by 29.4% during the 3rd quarter. State Street Corp now owns 1,399,729 shares of the company’s stock valued at $6,257,000 after acquiring an additional 317,952 shares during the period. Finally, Marshall Wace LLP acquired a new stake in Definitive Healthcare in the second quarter valued at approximately $1,535,000. 98.67% of the stock is currently owned by hedge funds and other institutional investors.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.